Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, the Netherlands.
Nutrition Research Foundation, Barcelona Science Park, Barcelona, Spain.
Nutr Diabetes. 2023 Apr 21;13(1):6. doi: 10.1038/s41387-023-00237-3.
Sweetened beverage intake may play a role in non-alcoholic fatty liver disease (NAFLD) development, but scientific evidence on their role is limited. This study examined associations between sugar-sweetened beverages (SSB), low/no-calorie beverages (LNCB) and fruit juice (FJ) intakes and NAFLD in four European studies.
Data for 42,024 participants of Lifelines Cohort, NQPlus, PREDIMED-Plus and Alpha Omega Cohort were cross-sectionally analysed. NAFLD was assessed using Fatty Liver Index (FLI) (≥60). Restricted cubic spline analyses were used to visualize dose-response associations in Lifelines Cohort. Cox proportional hazard regression analyses with robust variance were performed for associations in individual cohorts; data were pooled using random effects meta-analysis. Models were adjusted for demographic, lifestyle, and other dietary factors.
Each additional serving of SSB per day was associated with a 7% higher FLI-defined NAFLD prevalence (95%CI 1.03-1.11). For LNCB, restricted cubic spline analysis showed a nonlinear association with FLI-defined NAFLD, with the association getting stronger when consuming ≤1 serving/day and levelling off at higher intake levels. Pooled Cox analysis showed that intake of >2 LNCB servings/week was positively associated with FLI-defined NAFLD (PR 1.38, 95% CI 1.15-1.61; reference: non-consumers). An inverse association was observed for FJ intake of ≤2 servings/week (PR 0.92, 95% CI: 0.88-0.97; reference: non-consumers), but not at higher intake levels. Theoretical replacement of SSB with FJ showed no significant association with FLI-defined NAFLD prevalence (PR 0.97, 95% CI 0.95-1.00), whereas an adverse association was observed when SSB was replaced with LNCB (PR 1.12, 95% CI 1.03-1.21).
Pooling results of this study showed that SSB and LNCB were positively associated with FLI-defined NAFLD prevalence. Theoretical replacement of SSB with LNCB was associated with higher FLI-defined NAFLD prevalence. An inverse association was observed between moderate intake of FJ and FLI-defined NAFLD. Our results should be interpreted with caution as reverse causality cannot be ruled out.
含糖饮料的摄入可能在非酒精性脂肪性肝病(NAFLD)的发展中起作用,但关于其作用的科学证据有限。本研究在四项欧洲研究中,检查了含糖饮料(SSB)、低/无热量饮料(LNCB)和果汁(FJ)摄入与 NAFLD 之间的关联。
对 Lifelines 队列、NQPlus、PREDIMED-Plus 和 Alpha Omega 队列的 42024 名参与者进行了横断面分析。使用脂肪性肝病指数(FLI)(≥60)评估 NAFLD。使用 Lifelines 队列中的受限立方样条分析来可视化剂量反应关联。使用稳健方差的 Cox 比例风险回归分析对各个队列中的关联进行分析;使用随机效应荟萃分析对数据进行合并。模型调整了人口统计学、生活方式和其他饮食因素。
每天额外摄入一份 SSB,FLI 定义的 NAFLD 患病率增加 7%(95%CI 1.03-1.11)。对于 LNCB,受限立方样条分析显示与 FLI 定义的 NAFLD 呈非线性关联,当每天摄入≤1 份时关联增强,而在更高的摄入水平时趋于平稳。汇总的 Cox 分析表明,每周摄入>2 份 LNCB 与 FLI 定义的 NAFLD 呈正相关(PR 1.38,95%CI 1.15-1.61;参考:非消费者)。每周摄入≤2 份 FJ 与 FLI 定义的 NAFLD 呈负相关(PR 0.92,95%CI:0.88-0.97;参考:非消费者),但在更高的摄入水平则没有观察到这种关联。用 FJ 替代 SSB 的理论分析显示与 FLI 定义的 NAFLD 患病率无显著关联(PR 0.97,95%CI 0.95-1.00),而用 LNCB 替代 SSB 则与 FLI 定义的 NAFLD 患病率呈正相关(PR 1.12,95%CI 1.03-1.21)。
本研究的汇总结果表明,SSB 和 LNCB 与 FLI 定义的 NAFLD 患病率呈正相关。用 LNCB 替代 SSB 的理论分析与 FLI 定义的 NAFLD 患病率升高有关。中等摄入 FJ 与 FLI 定义的 NAFLD 呈负相关。由于不能排除反向因果关系,因此应谨慎解释我们的研究结果。